Patent · US Active

Separation moieties and methods of use thereof

US11739132B2 · kind B2 · utility

0Cited by

82References

16Claims

0Family size

Assignee

Werewolf Therapeutics, Inc. · US

Inventors

William Winston · Marlborough, US
Luke Evnin · San Francisco, US
Vinay Bhaskar · South San Francisco, US
Giselle KNUDSEN · San Anselmo, US
Daniel Hicklin · Montclair, US
Cynthia Seidel-Dugan · Belmont, US
Jose Andres Salmeron Garcia · Westminster, US
Heather Brodkin · Newton, US

Key dates

Filing date	Feb 22, 2022
Grant date	Aug 29, 2023
Priority date	—
Expiry date	Feb 22, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/70
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are separation moieties that are suitable for use in conjunction with a variety of therapeutic payloads. The separation moieties serve to generate conditionally active macromolecules whereby the macromolecules have reduced or minimal biological activity until the separation moieties are modified under specific conditions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.